Xcout IntelIgnis Therapeutics competitors & alternatives
The 12 closest competitors and alternatives to Ignis Therapeutics among biotechnology companies — ranked by similarity to what Ignis Therapeutics actually does, not by market-cap band.
Subscribe to see Ignis Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Ignis Therapeutics
Ignis Therapeutics is a biotechnology company established in late 2020 and headquartered in Shanghai, China. The company is dedicated to discovering and developing therapeutics for central nervous system (CNS) diseases.
Ignis Therapeutics at a glance
Ignis Therapeutics is a biotechnology company headquartered in China. Its most recent funding round, Series A, raised $180M in November 2021. Xcout tracks 13 named people at Ignis Therapeutics, including Vicky Zhang (首席财务官).
Ignis Therapeutics leadership
- Vicky Zhang首席财务官
- 方群首席科学官，翼思脑科学创新研发中心负责人
- 陈连勇翼思生物 董事长
- 黎强首席运营官
- 龙爱晶首席执行官兼首席医学官
- 孙沂杉生物部副总裁
7 more named people on record for Ignis Therapeutics, with roles, board committees and tenure — see the full roster →
Ignis Therapeutics funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $180M | 10 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Ignis Therapeutics competitors
Ranked by semantic similarity — how close each company is to Ignis Therapeutics by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotech
Inventisbio is a biopharmaceutical company that focuses on the discovery and development of innovative drugs for major diseases such as tumors, autoimmune diseases, and metabolic disorders. Utilizing an independent research and development platform, the company creates proprietary drug pipelines targeting oncology drivers, kinases, and autoimmune pathways to serve patients globally.
Similar biotechnology company
Anacalypsis Therapeutics is a biotechnology innovation company based at the Athens Life Tech Park in Greece, focusing on developing medications and biomarkers for central nervous system diseases.
Similar biotechnology company
ETERN Therapeutics is a biopharmaceutical company headquartered in Shanghai, China, operating with a strong academic atmosphere and focus on biotechnology.
Similar biotechnology company
Axonis Therapeutics, Inc. is a biotechnology company headquartered in Boston, Massachusetts, focused on discovering and developing novel treatments for neurological conditions and spinal cord injuries. Founded in 2019, the company advances therapeutic candidates through its proprietary research platform.
Similar biotechnology company
Novoron Bioscience, Inc. is a San Diego-based biotechnology company developing novel therapeutics to address central nervous system and other conditions.
Similar biotechnology company
Syremis Therapeutics Ltd. is a clinical-stage biopharmaceutical company headquartered in Tel Aviv, Israel, dedicated to developing novel drug pipeline medicines targeted at treating diseases of the nervous system and mental health disorders.
Similar biotechnology company
Myrobalan Therapeutics is a pre-clinical biotechnology company headquartered in Medford, Massachusetts, focused on developing oral small molecule therapies for central nervous system and neurodegenerative diseases. The company targets novel mechanisms to create neurorestorative treatments for CNS disorders.
Similar biotechnology company
Asceneuron is a biotechnology research company founded in 2012 and headquartered in Eysins, Switzerland, focusing on the discovery and development of therapeutics for neurodegenerative disorders.
Life Sciences (Therapeutics)
Eumentis Therapeutics, Inc. is a clinical-stage biopharmaceutical company headquartered in San Diego, California, dedicated to developing novel therapies for serious neuropsychiatric conditions.
Life Sciences
Cajal Neuroscience (Cajal Therapeutics Inc.) is a biotechnology company headquartered in Seattle, Washington. The company is dedicated to advancing therapeutic pipelines in neuroscience research.
Similar biotechnology company
Aptinyx Inc. is an Evanston, Illinois-based clinical-stage biotechnology company focused on discovering and developing innovative therapies for challenging disorders of the brain and nervous system.
Similar biotechnology company
FoldLogic Bio is a clinical-stage biotechnology company developing targeted immunotherapies for neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and Multiple System Atrophy. The company focuses on modulating the central nervous system's immune responses, specifically targeting microglial activity, alpha-synuclein, and TREM2 to halt disease progression.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Ignis Therapeutics and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Ignis Therapeuticsand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →